Outlook Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.985; its P/E ratio is -2.20; Outlook Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.91. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -10.37M	$ -13.30M	$ -21.07M	$ -6.65M	$ -16.21M
EBITDA	$ -10.35M	$ -13.29M	$ -21.06M	$ -6.64M	$ -16.20M
Net Income Common Stockholders	$ -11.18M	$ -12.99M	$ -20.68M	$ -6.65M	$ -18.66M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 10.36M	$ 23.39M	$ 33.71M	$ 43.63M	$ 52.34M
Total Assets	$ 21.68M	$ 32.30M	$ 44.45M	$ 54.02M	$ 62.69M
Total Debt	$ 36.55M	$ 35.56M	$ 34.74M	$ 31.84M	$ 31.85M
Net Debt	$ 26.19M	$ 12.16M	$ 1.03M	$ -11.79M	$ -20.49M
Total Liabilities	$ 46.03M	$ 46.74M	$ 49.93M	$ 43.53M	$ 46.93M
Stockholders Equity	$ -24.34M	$ -14.44M	$ -5.48M	$ 10.50M	$ 15.76M
Cash Flow	-
Free Cash Flow	$ -13.03M	$ -12.74M	$ -13.22M	$ -8.11M	$ -8.90M
Operating Cash Flow	$ -13.03M	$ -12.74M	$ -13.22M	$ -8.11M	$ -8.90M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -3.18K	$ 2.42M	$ 3.30M	$ -597.13K	$ 43.85M

Currency in USD

Outlook Therapeutics Earnings and Revenue History

Income Statement >

Outlook Therapeutics Debt to Assets

Balance Sheet >

Outlook Therapeutics Cash Flow

Cash Flow >

Outlook Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing